MLSS News and Press, Milestone Scientific Inc. From 05/16/23

ROSELAND, N.J., May 16, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery systems that provide painless and precise injections, today announced that it has commenced sales of CompuFlo ® Epidural disposables ...

2023-05-11 13:25:06 ET Milestone Scientific Inc. (MLSS) Q1 2023 Earnings Conference Call May 10, 2023 8:30 AM ET Company Participants David Waldman – Investor Relations Arjan Haverhals – Chief Executive Officer Peter Milligan – Chief Financia...

2023-05-11 07:03:38 ET Milestone Scientific press release ( NYSE: MLSS ): Q1 GAAP EPS of -$0.02 in-line. Revenue of $2.59M (-4.1% Y/Y) beats by $0.09M . For further details see: Milestone Scientific GAAP EPS of -$0.02 in-line, revenue of $2.59M beats by $0.09M

ROSELAND, N.J., May 11, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the first quarter ended Ma...

ROSELAND, N.J., May 10, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of computerized drug delivery instruments that provide painless and precise injections, as well as AI-assisted medical technology, today announced the successful completion of the fir...

ROSELAND, N.J., May 09, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery systems that provide painless and precise injections, today announced that it has commenced sales of CompuFlo ® Epidural disposables i...

ROSELAND, N.J., May 05, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Thursday, May 11,...

2023-03-31 19:34:07 ET Milestone Scientific Inc. (MLSS) Q4 2022 Results Conference Call March 31, 2023 08:30 AM ET Company Participants David Waldman - Investor Relations Arjan Haverhals - Chief Executive Officer Peter Milligan - Chief Financial Officer of Milest...

2023-03-31 08:24:01 ET Milestone Scientific press release ( NYSE: MLSS ): FY GAAP EPS of -$0.12. Revenue of $8.81M (-14.5% Y/Y). For further details see: Milestone Scientific GAAP EPS of -$0.12, revenue of $8.81M

ROSELAND, N.J., March 31, 2023 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS) , a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced financial results for the year ending December...